Plus Therapeutics News

Plus Therapeutics Is Maintained at Buy by Ascendiant Capital

Dow JonesSep 3 05:45 ET

Buy Rating Affirmed for Plus Therapeutics Amid Strong Clinical Results and Positive Financial Outlook

TipRanksAug 20 04:57 ET

Maxim Group Maintains Plus Therapeutics(PSTV.US) With Buy Rating, Maintains Target Price $4

Moomoo NewsAug 16 13:32 ET

Buy Rating Affirmed for Plus Therapeutics on Strong Financials and Promising Clinical Trials

TipRanksAug 16 12:47 ET

Plus Therapeutics Analyst Ratings

BenzingaAug 16 08:20 ET

Buy Rating Affirmed for Plus Therapeutics Amidst Promising Clinical Trial Results

TipRanksAug 15 14:37 ET

Buy Rating Affirmed for Plus Therapeutics on Strong Clinical Progress and Robust Financial Health

TipRanksJun 3 06:05 ET

Buy Rating Justified by Plus Therapeutics' Strategic Acquisition and Strong Pipeline Prospects

TipRanksMay 23 07:40 ET

Analysts' Top Healthcare Picks: OrganiGram Holdings (OGI), Plus Therapeutics (PSTV)

TipRanksMay 17 16:15 ET

Analysts Offer Insights on Healthcare Companies: Charles River Labs (CRL), Plus Therapeutics (PSTV) and Argenx Se (ARGX)

TipRanksMay 10 08:45 ET

Buy Rating Affirmed for Plus Therapeutics Amidst Clinical Advancements and Industry Tailwinds

TipRanksMar 22 12:50 ET

Analysts Offer Insights on Healthcare Companies: Plus Therapeutics (PSTV) and Milestone Pharmaceuticals (MIST)

TipRanksMar 22 12:40 ET

Buy Rating Affirmed for Plus Therapeutics Amid Strong Financials and Promising Clinical Trials

TipRanksMar 7 10:45 ET

Analysts Offer Insights on Healthcare Companies: Halozyme (HALO), HUTCHMED (HCM) and Plus Therapeutics (PSTV)

TipRanksNov 28, 2023 16:40 ET

Analysts Offer Insights on Healthcare Companies: Plus Therapeutics (PSTV), Ambrx Biopharma (AMAM) and Marinus (MRNS)

TipRanksNov 21, 2023 06:20 ET

Analysts Offer Insights on Healthcare Companies: Plus Therapeutics (PSTV), Beyond Air (XAIR) and Ovid Therapeutics (OVID)

TipRanksNov 3, 2023 14:50 ET

Analysts Conflicted on These Healthcare Names: Geron (GERN), Silk Road Medical (SILK) and Plus Therapeutics (PSTV)

TipRanksNov 2, 2023 12:50 ET

Promising Clinical Developments Drive Buy Rating for Plus Therapeutics: Analysis of Recent Trials and Future Prospects

TipRanksOct 11, 2023 13:45 ET

JonesTrading Sticks to Its Buy Rating for Plus Therapeutics (PSTV)

TipRanksSep 11, 2023 12:05 ET

Analysts Offer Insights on Healthcare Companies: Actinium Pharmaceuticals (ATNM) and Plus Therapeutics (PSTV)

TipRanksAug 16, 2023 12:00 ET